Shire Pharma (Uk) closes a good quarter
Posted in finance on February 28th, 2010 by adminThe British group Shire Pharmaceuticals has closed the third quarter with net income growing by 54% over the previous quarter. The performance of the company was supported by the boom in sales that has covered the drug Adderall. Profit before tax was 53.3 million pounds against 34.6 million a year ago. The sales reached 149.6 million pounds, compared with 122.5 million the same period in 2000. In particular, sales of Adderall have increased by 45% from a year ago. At this time, the title Shire Pharmaceuticals sells the 3.5% share at £ 10:25.